Clinical trial NCT05633888: Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System
Official title: Prospective, Multi-Center, Single Arm Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Sacroiliac Joint Disruption
Degenerative Sacroiliitis
Lead sponsor: Tenon Medical
Sponsor class: INDUSTRY
First posted: 2022-12-01
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: OTHER

Brief summary: The purpose of this study is to evaluate the outcomes of patients with sacroiliac joint pain treated with the CATAMARAN SI Joint Fusion System.

Detailed description: This is a multi-center post-market study to evaluate the clinical outcomes of patients with sacroiliac joint disruptions or degenerative sacroiliitis treated with the CATAMARAN SI Joint Fusion System.

Eligibility criteria: Inclusion Criteria:

* Diagnosis of sacroiliac joint disruption or degenerative sacroiliitis based on ALL of the following:

  * Patient has pain at or close to the posterior superior iliac spine (PSIS) with possible radiation into buttocks, posterior thigh or groin and can point with a single finger to the location of pain (Fortin Finger Test), and
  * Patient has at least 3 of 5 physical examination maneuvers specific for SI joint pain (Fabers, Compression, Distraction,Thigh thrust, Gaenslen's test, and/or Sacral thrust test), and
  * Patient has improvement in lower back pain VAS of at least 50% of the pre injection VAS after fluoroscopic controlled injection of local anesthetic into affected SI joint(s) (including previous documented test \<6 months ago)
* Patient has failed conservative care (non-surgical) \> 6 months
* Patient has a pre-operative Oswestry Disability Index score \> 30%
* Patient has a pre-operative SI joint pain score of \> 50 on a 0-100 mm visual analog scale (VAS)
* Patient, or authorized representative, signs a written Informed Consent form to participate in the study
* Patient is willing and able to complete study follow-up requirements

Exclusion Criteria:

* Planned bi-lateral SI joint fixation
* Severe lower back pain due to other causes, such as lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degeneration, and lumbar vertebral body fracture (this is done by physical exam, medical history, and MRI/CT/X-ray as required)
* Other known sacroiliac pathology such as: sacral dysplasia, inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA- associated spondyloarthropathy), tumor, acute fracture, crystal arthropathy
* History of recent (\<1 year) fracture of the pelvis with documented malunion, non-union of sacrum or ilium or any type of internal fixation of the pelvic ring
* Severe osteoporosis
* Paget's disease, osteomalacia, osteomalacia or other metabolic bone disease
* Any condition or anatomy that makes treatment with the CATAMARAN SI Joint Fusion System infeasible including deformity
* Known allergy to titanium or titanium alloys
* Morbid obesity
* Active malignancy: a history of any invasive malignancy (except non-melanoma skin cancer), unless the subject has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least five years
* Patient has systemic infection or active infection at the treatment site
* Chronic rheumatologic condition (e.g., rheumatoid arthritis)
* Patient has uncontrolled diabetes
* Patient is currently receiving or seeking worker's compensation, disability remuneration, and/or involved in injury litigation
* Prominent neurologic condition that would interfere with physical therapy
* Patient is pregnant or wishes to become pregnant in the next two years
* Patient is not likely to comply with the follow-up evaluation schedule
* Patient is participating in a clinical trial of another investigational drug or device in which the primary endpoint has not occurred
* Patient has a psychiatric disease (e.g., schizophrenia, major depression, personality disorders) that could interfere with study participation
* Known or suspected drug or alcohol abuse
* Patient is a prisoner or a ward of the state

Primary outcomes:
measure: Proportion of subjects that meet the definition of Subject Success at 6 months post-procedure
timeFrame: 6 months post procedure
Secondary outcomes:
Other outcomes:
Locations:
city: Coeur d'Alene
country: United States
facility: Northwest Specialty Hospital
state: Idaho
city: Muncie
country: United States
facility: Comprehensive Pain and Spine Specialists
state: Indiana
city: Louisville
country: United States
facility: Vitality Pain Centers
state: Kentucky
city: Duluth
country: United States
facility: Orthopedic Associates of Duluth
state: Minnesota
city: Chesterfield
country: United States
facility: St. Louis Pain Consultants
state: Missouri
city: Saint George
country: United States
facility: St. George Orthopedic Spine
state: Utah
Study officials:
References: